Biosimilars Canada has compiled a list of news stories from Canada and abroad about biosimilars that may be of interest to readers. These links to third-party websites are provided for informational purposes only, and do represent an endorsement from our organization. Biosimilars Canada’s statements and news releases are available here.
Ontario can save $155 million annually with switch to biosimilars
In this CFRB Newstalk 1010 interview Biosimilars Canada President Jim Keon discusses how Ontario can save money and support pharmaceutical investment through the implementation of a biosimilars switching policy.
Nova Scotia becomes sixth jurisdiction to implement biosimilar switching
As the Generics Bulletin reports, half of Canada’s provinces have now announced biosimilar switching policies.
Nova Scotia becomes fifth Canadian province to implement a biosimilar switching program
Report from the AJMC Center for Biosimilars on Nova Scotia’s new biosimilar switching initiative.
Switch to biosimilar drugs may save N.S. millions of dollars
CBC News coverage of the announcement of Nova Scotia’s biosimilar switching policy, which is expected to save the province more than $13 million annually.